Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new institute for nanoscience research is to open in Oxford thanks to a $10 million gift from The Kavli Foundation.

Biochemistry Building Completion

The new Kavli Institute for NanoScience Discovery (Kavli INSD) at Oxford will be a unique combination of structural biology with world-leading biochemistry, pathology, chemistry, physics, physiology and engineering. Based in a new building at the centre of Oxford’s Science Area site, it will house more than 40 faculty and 400 students, postdocs and research staff.

It will be the 20th Kavli Institute globally and The Kavli Foundation’s fifth institute in nanoscience when it opens its doors in January 2021.

Professor Gavin Screaton, Head of Oxford University’s Medical Sciences Division, said: “Oxford has a rich tradition as a research-driven university and the addition of a Kavli Institute will enhance that collaborative nature that helps us to deliver exceptional education, to carry out world-leading research, and to make significant contributions to society – locally, nationally and internationally.

'The multidisciplinary nature of nanoscience broadens the possibilities for discoveries, which can translate into innovations that can benefit economies and humanity worldwide, such as the development of the gene-editing technology CRISPR.'

The full story is available on the University of Oxford website

Similar stories

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).